Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors

NCT02616744 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

171

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Ibandronic acid
DRUG: Placebo

Sponsor

Azienda Ospedaliero-Universitaria Careggi